Castrén & Snellman advised Finnish Industry Investment Ltd (Tesi) on the deal. TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces it has completed...
TILT Biotherapeutics’ €10 Million Financing Round
Enics’ Merger With GPV International
Castrén & Snellman, Homburger and Plesner advised Ahlström Capital and its portfolio company Enics Group. GPV, Denmark’s largest electronics manufacturer, merges with Swiss-headquartered electronics manufacturer Enics....
Lifa Air’s Listing on First North
Castrén & Snellman advised Lifa Air Plc on the deal. Lifa Air Plc announced its listing on Nasdaq First North Growth Market Finland. The company raised...
F-Secure’s Proposed Separation of F-Secure’s Consumer Security Business Through Partial Demerger
Castrén & Snellman advised F-Secure Corporation on the deal. The Board of Directors of F-Secure Corporation has decided to pursue the separation of the Company’s Consumer Security...